Vimarsana
Biggest News Aggregation in the World

Transgenic Mice News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Transgenic Mice. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Transgenic Mice Today - Breaking & Trending Today

Researchers create transparent implant to decipher deep brain activity - Vimarsana News

Researchers create transparent implant to decipher deep brain activity

The study team tested this implant on transgenic mice. 

New Research in the Treatment of Parkinson's Disease - Vimarsana News

New Research in the Treatment of Parkinson's Disease

/PRNewswire/ -- Researchers at the University of Central Florida College of Medicine (UCF COM) in Orlando, Florida completed research that is very promising in...

New Research in the Treatment of Parkinson's Disease - Vimarsana News

New Research in the Treatment of Parkinson's Disease

Researchers at the University of Central Florida College of Medicine (UCF COM) in Orlando, Florida completed research that is very promising in the treatment of Parkinson's disease. They had attended a Parkinson's disease (PD) patient for a...

40th Anniversary Recollections & Predictions - Vimarsana News

40th Anniversary Recollections & Predictions

To help celebrate GEN’s 40th Anniversary with this special October issue, we asked scientists and business professionals in academia and industry to give us their reflections, impressions, and insights on the biotechnology industry and the life sciences.

Modified Vaccinia Ankara model vaccine prevents COVID-19 in transgenic mice study - Vimarsana News

Modified Vaccinia Ankara model vaccine prevents COVID-19 in transgenic mice study

Modified Vaccinia Ankara model vaccine prevents COVID-19 in transgenic mice study As the coronavirus disease 2019 (COVID-19) pandemic breaks out afresh over much of the world, vaccines are assuming greater significance. Several types of vaccines have been or are in the process of being developed against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of COVID-19. A recent paper, that appeared as a preprint on the bioRxiv* server in January 2021, shows the effectiveness of a novel recombinant vaccinia virus that expresses modified SARS-CoV-2 spike antigen...